Correlation Between Exagen and Natera
Can any of the company-specific risk be diversified away by investing in both Exagen and Natera at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Exagen and Natera into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Exagen Inc and Natera Inc, you can compare the effects of market volatilities on Exagen and Natera and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Exagen with a short position of Natera. Check out your portfolio center. Please also check ongoing floating volatility patterns of Exagen and Natera.
Diversification Opportunities for Exagen and Natera
Very weak diversification
The 3 months correlation between Exagen and Natera is 0.4. Overlapping area represents the amount of risk that can be diversified away by holding Exagen Inc and Natera Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Natera Inc and Exagen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Exagen Inc are associated (or correlated) with Natera. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Natera Inc has no effect on the direction of Exagen i.e., Exagen and Natera go up and down completely randomly.
Pair Corralation between Exagen and Natera
Considering the 90-day investment horizon Exagen Inc is expected to generate 2.96 times more return on investment than Natera. However, Exagen is 2.96 times more volatile than Natera Inc. It trades about 0.02 of its potential returns per unit of risk. Natera Inc is currently generating about -0.04 per unit of risk. If you would invest 428.00 in Exagen Inc on December 28, 2024 and sell it today you would lose (44.00) from holding Exagen Inc or give up 10.28% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Exagen Inc vs. Natera Inc
Performance |
Timeline |
Exagen Inc |
Natera Inc |
Exagen and Natera Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Exagen and Natera
The main advantage of trading using opposite Exagen and Natera positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Exagen position performs unexpectedly, Natera can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Natera will offset losses from the drop in Natera's long position.Exagen vs. Fonar | Exagen vs. Burning Rock Biotech | Exagen vs. Sera Prognostics | Exagen vs. Castle Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Complementary Tools
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
CEOs Directory Screen CEOs from public companies around the world |